Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selenium Chemoprevention in HGPIN
NCT00030901Phase 3Completed
- Sponsor
- SWOG Cancer Research Network
- Start
- Feb 2000
- Primary completion
- Nov 2011
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in prostate cancer (PCa) comparing L-selenomethionine with Placebo (2 arms). Primary endpoint: Presence of Carcinoma of the Prostate as Measured by Biopsy at 3 years. Started Feb 2000; status: completed.
02
Drugs
selenomethionine
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00030901.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00030901.